estd59

Organism:
Human
Study type:
Control Set
Submitter:
Richard Durbin
Description:
This study contains all structural variation data for the first phase of the 1000 Genomes Project (1K Genomes, 1KG). This includes Deletions, Mobile Element Insertions, Tandem Duplications, and Novel Sequences for both Pilot1 and Pilot2 on all chromosomes. Pilot1 structural variations were determined by low coverage re-sequencing of HapMap samples. Pilot2 structural variations were determined by high coverage re-sequencing of two HapMap trios (YRI and CEU).
Project:
28889
Publication(s):
Durbin et al. 2010

Detailed Information: Download 218039 Variant Regions, Download 2150366 Variant Calls, Download Both, FTP

Variant Summary

Assembly used for analysis:
Remapped: GRCh37 (hg19)
Remapped: GRCh37.p5 GRCh37.p5 contains hg19 and PATCH updates released by the GRC (Click to go to GRC website).
Submitted: NCBI36 (hg18)

Sequence IDChrNumber of Variant RegionsNumber of Variant CallsPlacement typeLink to graphical display
NC_000001.10Chr116,301160,365RemappedNC_000001.10
NC_000002.11Chr216,419164,967RemappedNC_000002.11
NC_000003.11Chr312,634125,038RemappedNC_000003.11
NC_000004.11Chr414,485158,503RemappedNC_000004.11
NC_000005.9Chr512,630132,646RemappedNC_000005.9
NC_000006.11Chr613,155140,335RemappedNC_000006.11
NC_000007.13Chr712,753123,475RemappedNC_000007.13
NC_000008.10Chr811,001114,662RemappedNC_000008.10
NC_000009.11Chr911,196103,738RemappedNC_000009.11
NC_000010.10Chr109,583101,438RemappedNC_000010.10
NC_000011.9Chr1110,247102,082RemappedNC_000011.9
NC_000012.11Chr129,48094,718RemappedNC_000012.11
NC_000013.10Chr137,42680,604RemappedNC_000013.10
NC_000014.8Chr147,22282,698RemappedNC_000014.8
NC_000015.9Chr155,69157,939RemappedNC_000015.9
NC_000016.9Chr167,17459,180RemappedNC_000016.9
NC_000017.10Chr177,45469,660RemappedNC_000017.10
NC_000018.9Chr186,17561,700RemappedNC_000018.9
NC_000019.9Chr196,77155,746RemappedNC_000019.9
NC_000020.10Chr204,69944,875RemappedNC_000020.10
NC_000021.8Chr213,49628,939RemappedNC_000021.8
NC_000022.10Chr224,50244,800RemappedNC_000022.10
NC_000023.10ChrX6,26734,940RemappedNC_000023.10
NC_000024.9ChrY8301,438RemappedNC_000024.9
Sequence IDChrNumber of Variant RegionsNumber of Variant CallsPlacement typeLink to graphical display
NT_167250.1Chr4|NT_167250.140866RemappedNT_167250.1
NT_113891.2Chr6|NT_113891.2436RemappedNT_113891.2
NW_003571040.1Chr7|NW_003571040.11832,125RemappedNW_003571040.1
NW_003315923.1Chr8|NW_003315923.122RemappedNW_003315923.1
NW_003571046.1Chr11|NW_003571046.124180RemappedNW_003571046.1
NW_003315943.1Chr15|NW_003315943.117163RemappedNW_003315943.1
NW_003315947.1Chr17|NW_003315947.11121RemappedNW_003315947.1
NW_003315949.1Chr17|NW_003315949.11923,183RemappedNW_003315949.1
Sequence IDChrNumber of Variant RegionsNumber of Variant CallsPlacement typeLink to graphical display
NC_000001.9Chr116,317160,487SubmittedNC_000001.9
NC_000002.10Chr216,426165,009SubmittedNC_000002.10
NC_000003.10Chr312,634125,038SubmittedNC_000003.10
NC_000004.10Chr414,535159,596SubmittedNC_000004.10
NC_000005.8Chr512,644132,884SubmittedNC_000005.8
NC_000006.10Chr613,164140,389SubmittedNC_000006.10
NC_000007.12Chr712,879125,101SubmittedNC_000007.12
NC_000008.9Chr811,021114,944SubmittedNC_000008.9
NC_000009.10Chr911,209103,842SubmittedNC_000009.10
NC_000010.9Chr109,617102,003SubmittedNC_000010.9
NC_000011.8Chr1110,249102,093SubmittedNC_000011.8
NC_000012.10Chr129,48294,734SubmittedNC_000012.10
NC_000013.9Chr137,42680,604SubmittedNC_000013.9
NC_000014.7Chr147,22582,715SubmittedNC_000014.7
NC_000015.8Chr155,70558,057SubmittedNC_000015.8
NC_000016.8Chr167,17659,196SubmittedNC_000016.8
NC_000017.9Chr177,54571,126SubmittedNC_000017.9
NC_000018.8Chr186,17561,700SubmittedNC_000018.8
NC_000019.8Chr196,77655,758SubmittedNC_000019.8
NC_000020.9Chr204,70044,883SubmittedNC_000020.9
NC_000021.7Chr213,49628,939SubmittedNC_000021.7
NC_000022.9Chr224,51244,843SubmittedNC_000022.9
NC_000023.9ChrX6,27534,957SubmittedNC_000023.9
NC_000024.8ChrY8511,468SubmittedNC_000024.8

SV remap statusSSV remap status
Sequence IDChrSVs on sourcePerfectGoodPassFailMultSSVs on sourcePerfectGoodPassFailMult
NC_000001.9Chr116,31716,1874470160160,487160,061622421220
NC_000002.10Chr216,42616,2822972736165,009164,04911860442196
NC_000003.10Chr312,63412,589271800125,038124,935544900
NC_000004.10Chr414,53514,36671383525159,596157,448508495686459
NC_000005.8Chr512,64412,5721741140132,884132,454201722380
NC_000006.10Chr613,16413,092283194140,389139,9351202445436
NC_000007.12Chr712,87912,548164542885125,101122,1521646176314813
NC_000008.9Chr811,02110,9214438180114,944114,0763552332800
NC_000009.10Chr911,20911,0735568130103,842103,148405501040
NC_000010.9Chr109,6179,5175214340102,003100,606784485650
NC_000011.8Chr1110,24910,197422224102,093101,7201716511180
NC_000012.10Chr129,4829,473432094,73494,6431164160
NC_000013.9Chr137,4267,425100080,60480,6004000
NC_000014.7Chr147,2257,1793493082,71582,46016078170
NC_000015.8Chr155,7055,6024632111458,05757,390186220108153
NC_000016.8Chr167,1767,156992059,19659,0271458160
NC_000017.9Chr177,5456,994249575519071,12663,80927984538323234
NC_000018.8Chr186,1756,163480061,70061,67419700
NC_000019.8Chr196,7766,73821125055,75855,54516140120
NC_000020.9Chr204,7004,6791551044,88344,84426580
NC_000021.7Chr213,4963,488710028,93928,9317100
NC_000022.9Chr224,5124,47681810044,84344,66722111430
NC_000023.9ChrX6,2756,17657338134,95734,71181147171
NC_000024.8ChrY8518131612101,4681,416202300

Samplesets

Number of Samplesets: 2

Sampleset ID:
1
Name:
HapMap_Samples
Description:
HapMap Samples
Size:
185
Sampleset Phenotype(s):
None
  • Download Samples as CSV file
  • Samples for sampleset 1 (displaying 100 of the 185 samples)
    Sample IDCell TypeSubject ID SexEthnicitySubject Phenotype
    NA18570B-LymphocyteNA18570FemaleHAN CHINESENone
    NA12812B-LymphocyteNA12812MaleUTAH/MORMONNone
    NA18502B-LymphocyteNA18502FemaleYORUBANone
    NA11993B-LymphocyteNA11993FemaleUTAH/MORMONNone
    NA18558B-LymphocyteNA18558MaleHAN CHINESENone
    NA18498B-LymphocyteNA18498MaleYORUBANone
    NA12813B-LymphocyteNA12813FemaleUTAH/MORMONNone
    NA12761B-LymphocyteNA12761FemaleUTAH/MORMONNone
    NA12154B-LymphocyteNA12154MaleUTAH/MORMONNone
    NA12156B-LymphocyteNA12156FemaleUTAH/MORMONNone
    NA18486B-LymphocyteNA18486MaleYORUBANone
    NA11881B-LymphocyteNA11881MaleUTAH/MORMONNone
    NA11831B-LymphocyteNA11831MaleUTAH/MORMONNone
    NA18532B-LymphocyteNA18532FemaleHAN CHINESENone
    NA18489B-LymphocyteNA18489FemaleYORUBANone
    NA18566B-LymphocyteNA18566FemaleHAN CHINESENone
    NA12751B-LymphocyteNA12751FemaleUTAH/MORMONNone
    NA12155B-LymphocyteNA12155MaleUTAH/MORMONNone
    NA18563B-LymphocyteNA18563MaleHAN CHINESENone
    NA18537B-LymphocyteNA18537FemaleHAN CHINESENone
    NA11920B-LymphocyteNA11920FemaleUTAH/MORMONNone
    NA12872B-LymphocyteNA12872MaleUTAH/MORMONNone
    NA18511B-LymphocyteNA18511FemaleYORUBANone
    NA12249B-LymphocyteNA12249FemaleUTAH/MORMONNone
    NA11830B-LymphocyteNA11830FemaleUTAH/MORMONNone
    NA12892B-LymphocyteNA12892FemaleUTAH/MORMONNone
    NA12716B-LymphocyteNA12716MaleUTAH/MORMONNone
    NA18555B-LymphocyteNA18555FemaleHAN CHINESENone
    NA12760B-LymphocyteNA12760MaleUTAH/MORMONNone
    NA12763B-LymphocyteNA12763FemaleUTAH/MORMONNone
    NA11995B-LymphocyteNA11995FemaleUTAH/MORMONNone
    NA18526B-LymphocyteNA18526FemaleHAN CHINESENone
    NA11931B-LymphocyteNA11931FemaleUTAH/MORMONNone
    NA18564B-LymphocyteNA18564FemaleHAN CHINESENone
    NA11829B-LymphocyteNA11829MaleUTAH/MORMONNone
    NA11894B-LymphocyteNA11894FemaleUTAH/MORMONNone
    NA11992B-LymphocyteNA11992MaleUTAH/MORMONNone
    NA12815B-LymphocyteNA12815FemaleUTAH/MORMONNone
    NA12749B-LymphocyteNA12749FemaleUTAH/MORMONNone
    NA12043B-LymphocyteNA12043MaleUTAH/MORMONNone
    NA18542B-LymphocyteNA18542FemaleHAN CHINESENone
    NA12003B-LymphocyteNA12003MaleUTAH/MORMONNone
    NA18501B-LymphocyteNA18501MaleYORUBANone
    NA06985B-LymphocyteNA06985FemaleUTAH/MORMONNone
    NA18520B-LymphocyteNA18520FemaleYORUBANone
    NA18508B-LymphocyteNA18508FemaleYORUBANone
    NA18505B-LymphocyteNA18505FemaleYORUBANone
    NA12044B-LymphocyteNA12044FemaleUTAH/MORMONNone
    NA18519B-LymphocyteNA18519MaleYORUBANone
    NA12234B-LymphocyteNA12234FemaleUTAH/MORMONNone
    NA18561B-LymphocyteNA18561MaleHAN CHINESENone
    NA10851B-LymphocyteNA10851MaleUTAH/MORMONNone
    NA12874B-LymphocyteNA12874MaleUTAH/MORMONNone
    NA12004B-LymphocyteNA12004FemaleUTAH/MORMONNone
    NA07347B-LymphocyteNA07347MaleUTAH/MORMONNone
    NA07357B-LymphocyteNA07357MaleUTAH/MORMONNone
    NA12776B-LymphocyteNA12776FemaleUTAH/MORMONNone
    NA06994B-LymphocyteNA06994MaleUTAH/MORMONNone
    NA18550B-LymphocyteNA18550FemaleHAN CHINESENone
    NA18510B-LymphocyteNA18510MaleYORUBANone
    NA12489B-LymphocyteNA12489FemaleUTAH/MORMONNone
    NA11919B-LymphocyteNA11919MaleUTAH/MORMONNone
    NA18562B-LymphocyteNA18562MaleHAN CHINESENone
    NA11840B-LymphocyteNA11840FemaleUTAH/MORMONNone
    NA12878B-LymphocyteNA12878FemaleUTAH/MORMONNone
    NA07051B-LymphocyteNA07051MaleUTAH/MORMONNone
    NA18573B-LymphocyteNA18573FemaleHAN CHINESENone
    NA18499B-LymphocyteNA18499FemaleYORUBANone
    NA11918B-LymphocyteNA11918FemaleUTAH/MORMONNone
    NA11994B-LymphocyteNA11994MaleUTAH/MORMONNone
    NA18571B-LymphocyteNA18571FemaleHAN CHINESENone
    NA12005B-LymphocyteNA12005MaleUTAH/MORMONNone
    NA06986B-LymphocyteNA06986MaleUTAH/MORMONNone
    NA10847B-LymphocyteNA10847FemaleUTAH/MORMONNone
    NA18545B-LymphocyteNA18545FemaleHAN CHINESENone
    NA12287B-LymphocyteNA12287FemaleUTAH/MORMONNone
    NA12006B-LymphocyteNA12006FemaleUTAH/MORMONNone
    NA12762B-LymphocyteNA12762MaleUTAH/MORMONNone
    NA18522B-LymphocyteNA18522MaleYORUBANone
    NA12144B-LymphocyteNA12144MaleUTAH/MORMONNone
    NA12891B-LymphocyteNA12891MaleUTAH/MORMONNone
    NA12814B-LymphocyteNA12814MaleUTAH/MORMONNone
    NA12045B-LymphocyteNA12045MaleUTAH/MORMONNone
    NA18523B-LymphocyteNA18523FemaleYORUBANone
    NA18516B-LymphocyteNA18516MaleYORUBANone
    NA18547B-LymphocyteNA18547FemaleHAN CHINESENone
    NA07346B-LymphocyteNA07346FemaleUTAH/MORMONNone
    NA18572B-LymphocyteNA18572MaleHAN CHINESENone
    NA12717B-LymphocyteNA12717FemaleUTAH/MORMONNone
    NA12873B-LymphocyteNA12873FemaleUTAH/MORMONNone
    NA07037B-LymphocyteNA07037FemaleUTAH/MORMONNone
    NA18507B-LymphocyteNA18507MaleYORUBANone
    NA18552B-LymphocyteNA18552FemaleHAN CHINESENone
    NA12750B-LymphocyteNA12750MaleUTAH/MORMONNone
    NA07000B-LymphocyteNA07000FemaleUTAH/MORMONNone
    NA18517B-LymphocyteNA18517FemaleYORUBANone
    NA11832B-LymphocyteNA11832FemaleUTAH/MORMONNone
    NA12828B-LymphocyteNA12828FemaleUTAH/MORMONNone
    NA18504B-LymphocyteNA18504MaleYORUBANone
    NA12414B-LymphocyteNA12414FemaleUTAH/MORMONNone
    Sampleset ID:
    2
    Name:
    HapMap_Trios
    Description:
    Two HapMap trios, one CEU, one YRI
    Size:
    6
    Sampleset Phenotype(s):
    None
  • Download Samples as CSV file
  • Samples for sampleset 2
    Sample IDCell TypeSubject ID SexEthnicitySubject Phenotype
    NA19240B-LymphocyteNA19240FemaleYORUBANone
    NA12892B-LymphocyteNA12892FemaleUTAH/MORMONNone
    NA19239B-LymphocyteNA19239MaleYORUBANone
    NA19238B-LymphocyteNA19238FemaleYORUBANone
    NA12878B-LymphocyteNA12878FemaleUTAH/MORMONNone
    NA12891B-LymphocyteNA12891MaleUTAH/MORMONNone

    Experimental Details

    Methods
    Number of Discovery Experiments: 17

    • Method ID:1
    • Method type:Sequencing
    • Description:
      Fragment libraries or paired-end libraries were constructed for each of the assigned samplesaccording to manuals "Genome Sequencer FLX and Genome Sequencer FLX Titanium Methods Manual" and "GS FLX Paired End DNA Library Preparation Method Manual". Each fragment and paired-end library was run on the Agilent Bioanalyzer 2100 to determine the library size, and the concentration determined by Ribo/PicoGreen assays. Libraries were then sequenced on the 454 FLX/Titanium platform using standard vendor emPCR, enrichment and sequencing methods.
    • Platforms:454 GS FLX
    • Method ID:2
    • Method type:Sequencing
    • Description:
      A combination of fragment and mate-paired libraries were utilized for sequencing on the SOLiD System V2.0 platform. SOLiD fragment libraries were constructed with 30ug of input DNA and an average insert size of 160 bp following standard vendor protocols (SOLiD System 2.0 Fragment Library Preparation) and sequenced as unidirectional reads of 25bp. DNA input ranged from 30 to 50ug for mate-paired libraries to insure library complexity (SOLiD System 2.0 Mate-Paired Library Preparation). Insert sizes of 1.5 and 2.5 kb were utilized for sequencing in the 2 X 25 bp format providing both sequence coverage and structural information. Each fragment and paired-end library was run on the Agilent Bioanalyzer 2100 to determine the library size, and the concentration determined by PicoGreen assays. Each fragment and mate-paired library was then sequenced on the SOLiD V2.0 platform following standard vendor methods for emPCR, enrichment, 3’ end modification and ligation sequencing (Applied Biosystems SOLiD System 2.0 User Guide).
    • Platforms:ABI SOLiD System
    • Method ID:3
    • Method type:Sequencing
    • Description:
      Illumina fragment libraries were prepared using 1 ug of high molecular weight genomic DNA according to manufacturer’s instructions, and the resulting libraries were sequenced on Illumina GA sequencers.
    • Platforms:Illumina Genome Analyzer II
    • Method ID:4
    • Method type:Sequencing
    • Description:
      Fragment libraries or paired-end libraries were constructed for each of the assigned samplesaccording to manuals "Genome Sequencer FLX and Genome Sequencer FLX Titanium Methods Manual" and "GS FLX Paired End DNA Library Preparation Method Manual". Each fragment and paired-end library was run on the Agilent Bioanalyzer 2100 to determine the library size, and the concentration determined by Ribo/PicoGreen assays. Libraries were then sequenced on the 454 FLX/Titanium platform using standard vendor emPCR, enrichment and sequencing methods.
    • Platforms:454 GS FLX
    • Method ID:5
    • Method type:Sequencing
    • Description:
      A combination of fragment and mate-paired libraries were utilized for sequencing on the SOLiD System V2.0 platform. SOLiD fragment libraries were constructed with 30ug of input DNA and an average insert size of 160 bp following standard vendor protocols (SOLiD System 2.0 Fragment Library Preparation) and sequenced as unidirectional reads of 25bp. DNA input ranged from 30 to 50ug for mate-paired libraries to insure library complexity (SOLiD System 2.0 Mate-Paired Library Preparation). Insert sizes of 1.5 and 2.5 kb were utilized for sequencing in the 2 X 25 bp format providing both sequence coverage and structural information. Each fragment and paired-end library was run on the Agilent Bioanalyzer 2100 to determine the library size, and the concentration determined by PicoGreen assays. Each fragment and mate-paired library was then sequenced on the SOLiD V2.0 platform following standard vendor methods for emPCR, enrichment, 3’ end modification and ligation sequencing (Applied Biosystems SOLiD System 2.0 User Guide).
    • Platforms:ABI SOLiD System
    • Method ID:6
    • Method type:Sequencing
    • Description:
      Illumina fragment libraries were prepared using 1 ug of high molecular weight genomic DNA according to manufacturer’s instructions, and the resulting libraries were sequenced on Illumina GA sequencers.
    • Platforms:Illumina Genome Analyzer II
    • Method ID:7
    • Method type:Sequencing
    • Description:
      Fragment libraries or paired-end libraries were constructed for each of the assigned samples according to manuals "Genome Sequencer FLX and Genome Sequencer FLX Titanium Methods Manual" and "GS FLX Paired End DNA Library Preparation Method Manual". Each fragment and paired-end library was run on the Agilent Bioanalyzer 2100 to determine the library size, and the concentration determined by Ribo/PicoGreen assays. Libraries were then sequenced on the 454 FLX/Titanium platform using standard vendor emPCR, enrichment and sequencing methods.
    • Platforms:454 GS FLX
    • Method ID:8
    • Method type:Sequencing
    • Description:
      Illumina fragment libraries were prepared using 1 ug of high molecular weight genomic DNA according to manufacturer’s instructions, and the resulting libraries were sequenced on Illumina GA sequencers.
    • Platforms:Illumina Genome Analyzer II
    • Method ID:9
    • Method type:Sequencing
    • Description:
      Fragment libraries or paired-end libraries were constructed for each of the assigned samples according to manuals "Genome Sequencer FLX and Genome Sequencer FLX Titanium Methods Manual" and "GS FLX Paired End DNA Library Preparation Method Manual". Each fragment and paired-end library was run on the Agilent Bioanalyzer 2100 to determine the library size, and the concentration determined by Ribo/PicoGreen assays. Libraries were then sequenced on the 454 FLX/Titanium platform using standard vendor emPCR, enrichment and sequencing methods.
    • Platforms:454 GS FLX
    • Method ID:10
    • Method type:Sequencing
    • Description:
      Illumina fragment libraries were prepared using 1 ug of high molecular weight genomic DNA according to manufacturer’s instructions, and the resulting libraries were sequenced on Illumina GA sequencers.
    • Platforms:Illumina Genome Analyzer II
    • Method ID:11
    • Method type:Sequencing
    • Description:
      Illumina fragment libraries were prepared using 1 ug of high molecular weight genomic DNA according to manufacturer’s instructions, and the resulting libraries were sequenced on Illumina GA sequencers.
    • Platforms:Illumina Genome Analyzer II
    • Method ID:12
    • Method type:Sequencing
    • Description:
      Illumina fragment libraries were prepared using 1 ug of high molecular weight genomic DNA according to manufacturer’s instructions, and the resulting libraries were sequenced on Illumina GA sequencers.
    • Platforms:Illumina Genome Analyzer II
    • Method ID:13
    • Method type:Sequencing
    • Description:
      Fragment libraries or paired-end libraries were constructed for each of the assigned samples according to manuals "Genome Sequencer FLX and Genome Sequencer FLX Titanium Methods Manual" and "GS FLX Paired End DNA Library Preparation Method Manual". Each fragment and paired-end library was run on the Agilent Bioanalyzer 2100 to determine the library size, and the concentration determined by Ribo/PicoGreen assays. Libraries were then sequenced on the 454 FLX/Titanium platform using standard vendor emPCR, enrichment and sequencing methods.
    • Platforms:454 GS FLX
    • Method ID:14
    • Method type:Sequencing
    • Description:
      A combination of fragment and mate-paired libraries were utilized for sequencing on the SOLiD System V2.0 platform. SOLiD fragment libraries were constructed with 30ug of input DNA and an average insert size of 160 bp following standard vendor protocols (SOLiD System 2.0 Fragment Library Preparation) and sequenced as unidirectional reads of 25bp. DNA input ranged from 30 to 50ug for mate-paired libraries to insure library complexity (SOLiD System 2.0 Mate-Paired Library Preparation). Insert sizes of 1.5 and 2.5 kb were utilized for sequencing in the 2 X 25 bp format providing both sequence coverage and structural information. Each fragment and paired-end library was run on the Agilent Bioanalyzer 2100 to determine the library size, and the concentration determined by PicoGreen assays. Each fragment and mate-paired library was then sequenced on the SOLiD V2.0 platform following standard vendor methods for emPCR, enrichment, 3’ end modification and ligation sequencing (Applied Biosystems SOLiD System 2.0 User Guide).
    • Platforms:ABI SOLiD System
    • Method ID:15
    • Method type:Sequencing
    • Description:
      Illumina fragment libraries were prepared using 1 ug of high molecular weight genomic DNA according to manufacturer’s instructions, and the resulting libraries were sequenced on Illumina GA sequencers.
    • Platforms:Illumina Genome Analyzer II
    • Method ID:16
    • Method type:Sequencing
    • Description:
      Combined Illumina and 454 Sequencing
    • Platforms:Illumina Genome Analyzer II and 454 GS FLX
    • Method ID:17
    • Method type:Sequencing
    • Description:
      Combined Illumina and SOLiD Sequencing
    • Platforms:Illumina Genome Analyzer II and ABI SOLiD System

    Analyses

    • Analysis ID: 1
    • Method ID(s): 1
    • Sampleset ID(s): 1
    • Description:
      Sequencing platform: 454. Mapping algorithm: MOSAIK. Type of computational approach: split read alignment.
    • Detection method:MOSAIK
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 2
    • Method ID(s): 3
    • Sampleset ID(s): 1
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: MAQ. Type of computational approach: read depth analysis.
    • Detection method:MAQ
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 3
    • Method ID(s): 3
    • Sampleset ID(s): 1
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: MAQ. Type of computational approach: read pair mapping.
    • Detection method:MAQ
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 4
    • Method ID(s): 3
    • Sampleset ID(s): 1
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: A combination of MAQ and PINDEL. Type of computational approach: split read alignment.
    • Detection method:MAQ_And_PINDEL
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 5
    • Method ID(s): 3
    • Sampleset ID(s): 1
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: MOSAIK. Type of computational approach: read pair mapping.
    • Detection method:MOSAIK
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 6
    • Method ID(s): 2
    • Sampleset ID(s): 1
    • Description:
      Sequencing platform: SOLiD. Mapping algorithm: Corona. Type of computational approach: read pair mapping.
    • Detection method:CORONA
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 7
    • Method ID(s): 3
    • Sampleset ID(s): 1
    • Merged Analysis ID(s) 2
    • Description:
      Analysis structural variant merging of all supporting structural variant calls generated by type of computational approach: read depth analysis.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 8
    • Method ID(s): 2, 3
    • Sampleset ID(s): 1
    • Merged Analysis ID(s) 3, 5, 6
    • Description:
      Analysis structural variant merging of all supporting structural variant calls generated by type of computational approach: read pair mapping.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 9
    • Method ID(s): 1, 3
    • Sampleset ID(s): 1
    • Merged Analysis ID(s) 1, 4
    • Description:
      Merging of all supporting structural variant calls generated by type of computational approach: split read alignments.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 10
    • Method ID(s): 1, 2, 3
    • Sampleset ID(s): 1
    • Merged Analysis ID(s) 7, 8, 9
    • Description:
      Discovery structural variant merging of all analysis structural variants generated by each of the types of computational approaches (RP, RD, and SR).
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 11
    • Method ID(s): 4
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform 454. Mapping algorithm: BLAT. Type of computational approach: split read alignment.
    • Detection method:BLAT
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 12
    • Method ID(s): 4
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: 454. Mapping algorithm: MOSAIK. Type of computational approach: split read alignment.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 13
    • Method ID(s): 4
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: 454. Mapping algorithm: paired-end mapping. Type of computational approach: read pair mapping.
    • Detection method:PEM
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 14
    • Method ID(s): 6
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: MAQ. Type of computational approach: read depth analysis.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 15
    • Method ID(s): 6
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: MAQ. Type of computational approach: read pair mapping.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 16
    • Method ID(s): 6
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: A combination of MAQ and PINDEL. Type of computational approach: split read alignment.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 17
    • Method ID(s): 6
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: MOSAIK. Type of computational approach: read pair mapping.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 18
    • Method ID(s): 6
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: mrFAST. Type of computational approach: read depth analysis.
    • Detection method:MRFAST
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 19
    • Method ID(s): 6
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: mrFAST. Type of computational approach: read pair mapping.
    • Detection method:MRFAST
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 20
    • Method ID(s): 6
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: Combination of mrFAST and ABySS. Type of computational approach: assembly.
    • Detection method:MRFAST,ABYSS
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 21
    • Method ID(s): 6
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: SOAPdenovo. Type of computational approach: assembly
    • Detection method:SOAP
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 22
    • Method ID(s): 5
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: SOLiD. Mapping algorithm: MAPREADS. Type of computational approach: read pair mapping.
    • Detection method:MAPREADS
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 23
    • Method ID(s): 4, 6
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Combination of Whole Genome Illumina and 454. Mapping algorithm: CORTEX. Type of compuational approach: assembly.
    • Detection method:CORTEX
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 24
    • Method ID(s): 6
    • Sampleset ID(s): 2
    • Merged Analysis ID(s) 14, 18
    • Description:
      Analysis structural variant merging of all supporting structural variant calls generated by type of computational approach: read depth analysis.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 25
    • Method ID(s): 4, 5, 6
    • Sampleset ID(s): 2
    • Merged Analysis ID(s) 13, 15, 17, 19, 22
    • Description:
      Analysis structural variant merging of all supporting structural variant calls generated by type of computational approach: read pair mapping.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 26
    • Method ID(s): 4, 6
    • Sampleset ID(s): 2
    • Merged Analysis ID(s) 11, 12, 16
    • Description:
      Merging of all supporting structural variant calls generated by type of computational approach: split read alignments.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 27
    • Method ID(s): 6
    • Sampleset ID(s): 2
    • Merged Analysis ID(s) 20, 21, 23
    • Description:
      Analysis structural variant merging of all supporting structural variant calls generated by type of computational approach: assembly.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 28
    • Method ID(s): 4, 5, 6
    • Sampleset ID(s): 2
    • Merged Analysis ID(s) 24, 25, 26, 27
    • Description:
      Discovery structural variant merging of all analysis structtural variants generated by each of the types of computational approaches (AS, RP, RD, and SR).
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 29
    • Method ID(s): 8
    • Sampleset ID(s): 1
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: MOSAIK. Type of computational approach: read pair mapping.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 30
    • Method ID(s): 7
    • Sampleset ID(s): 1
    • Description:
      Sequencing platform: 454. Mapping algorithm: MOSAIK. Type of computational approach: split read alignment.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 31
    • Method ID(s): 7, 8
    • Sampleset ID(s): 1
    • Description:
      Sequencing platform: 454 and Illumina. Mapping algorithm: MOSAIK. Type of computational approach: read pair mapping and split read alignment.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 32
    • Method ID(s): 7, 8
    • Sampleset ID(s): 1
    • Merged Analysis ID(s) 29, 30, 31
    • Description:
      Analysis structural variant merging of all supporting structural variant calls generated by type of computational approach: read pair mapping and split read alignment.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 33
    • Method ID(s): 10
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: MOSAIK. Type of computational approach: read pair mapping.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 34
    • Method ID(s): 9
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: 454. Mapping algorithm: MOSAIK. Type of computational approach: split read alignment.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 35
    • Method ID(s): 9, 10
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: 454 and Illumina. Mapping algorithm: MOSAIK. Type of computational approach: read pair mapping and split read alignment.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 36
    • Method ID(s): 9, 10
    • Sampleset ID(s): 2
    • Merged Analysis ID(s) 33, 34, 35
    • Description:
      Analysis structural variant merging of all supporting structural variant calls generated by type of computational approach: read pair mapping and split read alignment.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 37
    • Method ID(s): 11
    • Sampleset ID(s): 1
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: SPANNER. Type of computational approach: read pair mapping.
    • Detection method:SPANNER
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 38
    • Method ID(s): 11
    • Sampleset ID(s): 1
    • Merged Analysis ID(s) 37
    • Description:
      Analysis structural variant merging of all supporting structural variant calls generated by type of computational approach: read pair mapping.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 39
    • Method ID(s): 12
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: SPANNER. Type of computational approach: read pair mapping.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 40
    • Method ID(s): 12
    • Sampleset ID(s): 2
    • Merged Analysis ID(s) 39
    • Description:
      Analysis structural variant merging of all supporting structural variant calls generated by type of computational approach: read pair mapping.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 41
    • Method ID(s): 16
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Combination of Whole Genome Illumina and 454. Mapping algorithm: CORTEX. Type of compuational approach:read pair mapping.
    • Detection method:Cortex
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 42
    • Method ID(s): 16
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Combination of Whole Genome Illumina and 454. Mapping algorithm: CORTEX and SOAP. Type of compuational approach:read pair mapping.
    • Detection method:SOAP_And_Cortex
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 43
    • Method ID(s): 16
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Combination of Whole Genome Illumina and 454. Mapping algorithm: CORTEX on reference. Type of compuational approach:read pair mapping.
    • Detection method:Cortex
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 44
    • Method ID(s): 16
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Combination of Whole Genome Illumina and 454. Mapping algorithm: CORTEX on reference and CORTEX de novo. Type of compuational approach:read pair mapping.
    • Detection method:Cortex
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 45
    • Method ID(s): 16
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Combination of Whole Genome Illumina and 454. Mapping algorithm: CORTEX on reference, CORTEX de novo, and SOAP. Type of compuational approach:read pair mapping.
    • Detection method:SOAP_And_Cortex
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 46
    • Method ID(s): 16
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Combination of Whole Genome Illumina and 454. Mapping algorithm: CORTEX on reference and SOAP. Type of compuational approach:read pair mapping.
    • Detection method:SOAP_And_Cortex
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 47
    • Method ID(s): 14
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: SOLiD. Mapping algorithm: MAPREADS. Type of computational approach: read pair mapping.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 48
    • Method ID(s): 15
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina: Mapping algorithm: NovelSeq. Type of compuational approach:read pair mapping.
    • Detection method:NovelSeq
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 49
    • Method ID(s): 16
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Combination of Whole Genome Illumina and 454. Mapping algorithm: CORTEX on reference and NovelSeq. Type of compuational approach:read pair mapping.
    • Detection method:NovelSeq_And_Cortex
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 50
    • Method ID(s): 15
    • Sampleset ID(s): 2
    • Description:
      Sequencing platform: Whole Genome Illumina. Mapping algorithm: SOAP. Type of compuational approach:read pair mapping.
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 51
    • Method ID(s): 17
    • Sampleset ID(s): 2
    • Description:
      Combination of Whole Genome Illumina and SOLiD. Mapping algorithm: SOAP and MAPREADS. Type of compuational approach:read pair mapping.
    • Detection method:SOAP_And_MAPREADS
    • Sample level: Yes
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)
    • Analysis ID: 52
    • Method ID(s): 14, 15, 16, 17
    • Sampleset ID(s): 2
    • Merged Analysis ID(s) 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51
    • Description:
      Analysis structural variant merging of all supporting structural variant calls generated by type of computational approach: read pair analysis.
    • Sample level: No
    • Reference organism: Human
    • Reference assembly:NCBI36 (hg18)

    Validations

    There are no validation data for this study.